GlassScriptPeripheral Vascular Undivided
Payments companies reported to CMS as associated with Peripheral Vascular Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Peripheral Vascular Undivided, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Peripheral Vascular Undivided
These are the largest totals companies reported as associated with Peripheral Vascular Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $15,618.92 |
| William Gray | Wynnewood, PA | Interventional Cardiology | $11,218.53 |
| Graham Peigh | Chicago, IL | Clinical Cardiac Electrophysiology | $10,136.01 |
| Karim Al-Azizi | Plano, TX | Interventional Cardiology | $5,822.09 |
| Edris Aman | Sacramento, CA | Cardiovascular Disease | $2,463.71 |
| Bruce Samuels | Beverly Hills, CA | Cardiovascular Disease | $1,369.09 |
| Firas Zahr | Portland, OR | Cardiovascular Disease | $1,127.69 |
| Mohammad Usmani | Scarborough, ME | Vascular Surgery | $1,049.32 |
| Pradeep Nair | Houma, LA | Interventional Cardiology | $960.81 |
| Scott Chadderdon | Portland, OR | Cardiovascular Disease | $896.38 |
Prescribed Peripheral Vascular Undivided?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.